https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08621-1
Antimicrobial resistance (AMR) was a leading cause of death globally in 2019. Sadly, COVID-19 has exacerbated AMR, nonetheless, the process of developing new antibiotics remains very challenging. This urgently requires the adoption of alternative approaches t…
Create an account or login to join the discussion